Sodium–glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction: A protocol for meta-analysis

BACKGROUND: Nearly half of patients with heart failure (HF) have preserved ejection fraction (EF) and the mortality and morbidity of patients with HF with preserved EF (HFpEF) are high. Patients with HFpEF are often elderly and their primary chronic symptom is severe exercise intolerance that result...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukuta, Hidekatsu, Hagiwara, Hiromi, Kamiya, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702224/
https://www.ncbi.nlm.nih.gov/pubmed/34941199
http://dx.doi.org/10.1097/MD.0000000000028448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702224/
https://www.ncbi.nlm.nih.gov/pubmed/34941199
http://dx.doi.org/10.1097/MD.0000000000028448

Ejemplares similares